Fecal microbiota transplants delivered via frozen capsules can help patients with severe food allergies build a higher tolerance to peanuts, according to a landmark study published in Science Translational Medicine. The research offers a novel therapeutic approach for the up to 6 million people affected by peanut allergies by targeting the gut microbiome.
Clinical Trial Results and Gut Microbiome Impact
The study evaluated 10 young adults with severe peanut allergies who received a one-time treatment of 36 frozen fecal transplant pills taken over the course of a few hours. According to the findings, three participants were able to consume multiple peanuts before having a reaction four months after the intervention.
Researchers noted that a second round of the study added antibiotics to the fecal transplant pills, which suggested that antimicrobial preparation increases the overall effectiveness of the microbiome transfer. The treatment works by increasing the production of bile salts by the liver, which break down fats for better absorption. Beneficial bacteria introduced during the transplant metabolize these bile salts more effectively, subsequently increasing the number of cells that regulate the immune system and protect against allergic reactions.
Did you know? Previous experiments by the research team showed that stool samples transferred from babies with food allergies into allergy-prone mice induced severe allergic reactions, while samples from healthy babies protected the animals.
Expert Insights on Restoring Oral Tolerance
“Food allergy reflects a failure of oral tolerance, the process by which the gut immune system learns to accept food,” Chatila stated in a press release. He explained that the right bacterial strains help restore this biological process by utilizing bile acid metabolites to promote protective immune cells.
Building on these results, the research team is currently developing a modified version of the treatment. This next iteration utilizes a purified, concentrated form of microbes designed to be stored in a refrigerator for easier access.
Future Outlook and Next Steps
While the initial results demonstrate clear potential, larger clinical trials are necessary to confirm the findings on a broader scale. Investigators also plan to identify specific patient populations most likely to benefit from the therapy and isolate additional beneficial bacteria for targeted probiotic treatments.
Frequently Asked Questions
How are the fecal transplants administered?
The treatment uses frozen oral capsules—often referred to in research settings as poop pills—which patients swallow over the course of a few hours.
How many patients showed improvement in the study?
Out of 10 young adult participants with severe peanut allergies, three were able to eat multiple peanuts before having a reaction four months post-treatment, according to the published data.
What is the biological mechanism behind the treatment?
Beneficial bacteria from healthy donors help metabolize bile salts produced by the liver, which increases the population of immune-regulating cells that enforce oral tolerance to foods.
Stay Informed on Medical Breakthroughs
Subscribe to our newsletter to receive the latest updates on clinical research, immunology, and healthcare innovations directly in your inbox.
Related reading